Loading…
One week eradication regimen for Helicobacter pylori
Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amo...
Saved in:
Published in: | The Lancet (British edition) 1991-11, Vol.338 (8777), p.1249-1252 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3 |
---|---|
cites | cdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3 |
container_end_page | 1252 |
container_issue | 8777 |
container_start_page | 1249 |
container_title | The Lancet (British edition) |
container_volume | 338 |
creator | Logan, R.P.H. Gummett, P.A. Misiewicz, J.J. Karim, Q.N. Walker, M.M. Baron, J.H. |
description | Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori. |
doi_str_mv | 10.1016/0140-6736(91)92111-E |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72458849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>014067369192111E</els_id><sourcerecordid>2210389178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</originalsourceid><addsrcrecordid>eNp9kE1rFEEQhhtR4ib6DxQGFdHDaFdPf14ECasRArkoeGv6o0Y6zk6v3bNK_r292SWCoFRBHeqp4uUh5AnQN0BBvqXAaS_VIF8ZeG0YAPTre2QFXPFecPX1PlndIQ_Jaa3XlFIuqTghJyA1k2JYEX41Y_cL8XuHxcUU3JLy3BX8ljY4d2Mu3QVOKWTvwoKl295MuaRH5MHopoqPj_OMfPmw_nx-0V9effx0_v6yD2KApR-jMZ5pDQJhiNELpTVjXBnpkXomQlQBpPTKgKBCMsMci-DG1j6C98MZeXn4uy35xw7rYjepBpwmN2PeVasYF1pz08Dnf4HXeVfmls0yBnTQBpRu1LN_UWC04VJzaBA_QKHkWguOdlvSxpUbC9Tuvdu9VLuXag3YW-923c6eHn_v_Abjn6OD6LZ_cdy7Gtw0FjeHVO8wQWUr1rB3Bwyb1p8Ji60h4RwwpoJhsTGn_-f4DfD3m4s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198946841</pqid></control><display><type>article</type><title>One week eradication regimen for Helicobacter pylori</title><source>EBSCOhost Business Source Ultimate</source><creator>Logan, R.P.H. ; Gummett, P.A. ; Misiewicz, J.J. ; Karim, Q.N. ; Walker, M.M. ; Baron, J.H.</creator><creatorcontrib>Logan, R.P.H. ; Gummett, P.A. ; Misiewicz, J.J. ; Karim, Q.N. ; Walker, M.M. ; Baron, J.H.</creatorcontrib><description>Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(91)92111-E</identifier><identifier>PMID: 1682653</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Algorithms ; Amoxicillin ; Amoxicillin - administration & dosage ; Anti-Ulcer Agents - administration & dosage ; Biological and medical sciences ; Digestive system ; Drug Administration Schedule ; Drug Combinations ; Drug Resistance, Microbial ; Drugs ; Dyspepsia ; Eradication ; Female ; Follow-Up Studies ; Gastritis ; Helicobacter Infections - diagnosis ; Helicobacter Infections - drug therapy ; Helicobacter pylori ; Helicobacter pylori - drug effects ; Helicobacter pylori - isolation & purification ; Humans ; Male ; Medical disorders ; Medical research ; Medical sciences ; Metronidazole ; Metronidazole - administration & dosage ; Middle Aged ; Organometallic Compounds - administration & dosage ; Patient Compliance ; Patients ; Pharmacology. Drug treatments ; Pyloric Antrum - microbiology ; Time Factors ; Ulcers</subject><ispartof>The Lancet (British edition), 1991-11, Vol.338 (8777), p.1249-1252</ispartof><rights>1991</rights><rights>1992 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Nov 16, 1991</rights><rights>Copyright Elsevier Limited Nov 16, 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</citedby><cites>FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5060602$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1682653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Logan, R.P.H.</creatorcontrib><creatorcontrib>Gummett, P.A.</creatorcontrib><creatorcontrib>Misiewicz, J.J.</creatorcontrib><creatorcontrib>Karim, Q.N.</creatorcontrib><creatorcontrib>Walker, M.M.</creatorcontrib><creatorcontrib>Baron, J.H.</creatorcontrib><title>One week eradication regimen for Helicobacter pylori</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Algorithms</subject><subject>Amoxicillin</subject><subject>Amoxicillin - administration & dosage</subject><subject>Anti-Ulcer Agents - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>Digestive system</subject><subject>Drug Administration Schedule</subject><subject>Drug Combinations</subject><subject>Drug Resistance, Microbial</subject><subject>Drugs</subject><subject>Dyspepsia</subject><subject>Eradication</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastritis</subject><subject>Helicobacter Infections - diagnosis</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - drug effects</subject><subject>Helicobacter pylori - isolation & purification</subject><subject>Humans</subject><subject>Male</subject><subject>Medical disorders</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Metronidazole</subject><subject>Metronidazole - administration & dosage</subject><subject>Middle Aged</subject><subject>Organometallic Compounds - administration & dosage</subject><subject>Patient Compliance</subject><subject>Patients</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyloric Antrum - microbiology</subject><subject>Time Factors</subject><subject>Ulcers</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rFEEQhhtR4ib6DxQGFdHDaFdPf14ECasRArkoeGv6o0Y6zk6v3bNK_r292SWCoFRBHeqp4uUh5AnQN0BBvqXAaS_VIF8ZeG0YAPTre2QFXPFecPX1PlndIQ_Jaa3XlFIuqTghJyA1k2JYEX41Y_cL8XuHxcUU3JLy3BX8ljY4d2Mu3QVOKWTvwoKl295MuaRH5MHopoqPj_OMfPmw_nx-0V9effx0_v6yD2KApR-jMZ5pDQJhiNELpTVjXBnpkXomQlQBpPTKgKBCMsMci-DG1j6C98MZeXn4uy35xw7rYjepBpwmN2PeVasYF1pz08Dnf4HXeVfmls0yBnTQBpRu1LN_UWC04VJzaBA_QKHkWguOdlvSxpUbC9Tuvdu9VLuXag3YW-923c6eHn_v_Abjn6OD6LZ_cdy7Gtw0FjeHVO8wQWUr1rB3Bwyb1p8Ji60h4RwwpoJhsTGn_-f4DfD3m4s</recordid><startdate>19911116</startdate><enddate>19911116</enddate><creator>Logan, R.P.H.</creator><creator>Gummett, P.A.</creator><creator>Misiewicz, J.J.</creator><creator>Karim, Q.N.</creator><creator>Walker, M.M.</creator><creator>Baron, J.H.</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19911116</creationdate><title>One week eradication regimen for Helicobacter pylori</title><author>Logan, R.P.H. ; Gummett, P.A. ; Misiewicz, J.J. ; Karim, Q.N. ; Walker, M.M. ; Baron, J.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Algorithms</topic><topic>Amoxicillin</topic><topic>Amoxicillin - administration & dosage</topic><topic>Anti-Ulcer Agents - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>Digestive system</topic><topic>Drug Administration Schedule</topic><topic>Drug Combinations</topic><topic>Drug Resistance, Microbial</topic><topic>Drugs</topic><topic>Dyspepsia</topic><topic>Eradication</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastritis</topic><topic>Helicobacter Infections - diagnosis</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - drug effects</topic><topic>Helicobacter pylori - isolation & purification</topic><topic>Humans</topic><topic>Male</topic><topic>Medical disorders</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Metronidazole</topic><topic>Metronidazole - administration & dosage</topic><topic>Middle Aged</topic><topic>Organometallic Compounds - administration & dosage</topic><topic>Patient Compliance</topic><topic>Patients</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyloric Antrum - microbiology</topic><topic>Time Factors</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Logan, R.P.H.</creatorcontrib><creatorcontrib>Gummett, P.A.</creatorcontrib><creatorcontrib>Misiewicz, J.J.</creatorcontrib><creatorcontrib>Karim, Q.N.</creatorcontrib><creatorcontrib>Walker, M.M.</creatorcontrib><creatorcontrib>Baron, J.H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Logan, R.P.H.</au><au>Gummett, P.A.</au><au>Misiewicz, J.J.</au><au>Karim, Q.N.</au><au>Walker, M.M.</au><au>Baron, J.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One week eradication regimen for Helicobacter pylori</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1991-11-16</date><risdate>1991</risdate><volume>338</volume><issue>8777</issue><spage>1249</spage><epage>1252</epage><pages>1249-1252</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>1682653</pmid><doi>10.1016/0140-6736(91)92111-E</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-6736 |
ispartof | The Lancet (British edition), 1991-11, Vol.338 (8777), p.1249-1252 |
issn | 0140-6736 1474-547X |
language | eng |
recordid | cdi_proquest_miscellaneous_72458849 |
source | EBSCOhost Business Source Ultimate |
subjects | Adolescent Adult Aged Aged, 80 and over Algorithms Amoxicillin Amoxicillin - administration & dosage Anti-Ulcer Agents - administration & dosage Biological and medical sciences Digestive system Drug Administration Schedule Drug Combinations Drug Resistance, Microbial Drugs Dyspepsia Eradication Female Follow-Up Studies Gastritis Helicobacter Infections - diagnosis Helicobacter Infections - drug therapy Helicobacter pylori Helicobacter pylori - drug effects Helicobacter pylori - isolation & purification Humans Male Medical disorders Medical research Medical sciences Metronidazole Metronidazole - administration & dosage Middle Aged Organometallic Compounds - administration & dosage Patient Compliance Patients Pharmacology. Drug treatments Pyloric Antrum - microbiology Time Factors Ulcers |
title | One week eradication regimen for Helicobacter pylori |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A45%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One%20week%20eradication%20regimen%20for%20Helicobacter%20pylori&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Logan,%20R.P.H.&rft.date=1991-11-16&rft.volume=338&rft.issue=8777&rft.spage=1249&rft.epage=1252&rft.pages=1249-1252&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(91)92111-E&rft_dat=%3Cproquest_cross%3E2210389178%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=198946841&rft_id=info:pmid/1682653&rfr_iscdi=true |